Roche, Stanford Use Hap-based Software on Mice to Study Warfarin Metabolism; Pharmacodynamics Next | GenomeWeb

Researchers from Roche and Stanford University are developing a computational method that may be able to help drug and diagnostic makers better understand the genetic pathways related to drug response and disease mechanisms.

The method, which is currently only applicable to mice, but might eventually be developed for human use, uses haplotype data to compare genomic differences among mouse strains that could help predict drug metabolism. The researchers also believe the technique could help shed additional light on toxicology and pharmacodynamics.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: role for RNA splicing in genetic variation, and more.

An advocacy group sues the US Food and Drug Administration over redactions of information about advisory committee members, Stat News reports.

Mexico is trying to lure young genomics researchers back home with their own labs, Science reports.

A molecular autopsy has aided a woman's search for why sudden cardiac death has stalked her family, the Wall Street Journal reports.